These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1726733)

  • 1. Flunarizine in the treatment of vestibular vertigo: experimental and clinical data.
    Schmidt R; Oestreich W
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S27-30. PubMed ID: 1726733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flunarizine in migraine prophylaxis: the clinical experience.
    Schmidt R; Oestreich W
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S21-6. PubMed ID: 1726732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flunarizine and betahistine. Two different therapeutic approaches in vertigo compared in a double-blind study.
    Elbaz P
    Acta Otolaryngol Suppl; 1988; 460():143-8. PubMed ID: 3074614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trial of amitriptyline versus flunarizine as treatment of vestibular diseases. A preliminary study].
    Pardal Refoyo JL; Beltrán Mateos LD
    Acta Otorrinolaringol Esp; 1991; 42(6):433-7. PubMed ID: 1790064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drug.
    Rascol O; Clanet M; Montastruc JL
    Fundam Clin Pharmacol; 1989; 3 Suppl():79s-87s. PubMed ID: 2693294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vertigo, particularly of vascular origin, treated with flunarizine (R 14 950).
    Boniver R
    Acta Otorhinolaryngol Belg; 1979; 33(2):270-81. PubMed ID: 495086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vertigo, particularly of vascular origin, treated with flunarizine (R 14 950).
    Boniver R
    Arzneimittelforschung; 1978; 28(10):1800-4. PubMed ID: 582686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and pharmacodynamics of flunarizine in multimorbid, geriatric patients with vertigo].
    Rolzhäuser HP; Oestreich W; Seiler KU; Peters T; Platt D; Jorisch D
    Arzneimittelforschung; 1991 Feb; 41(2):109-14. PubMed ID: 2043170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of flunarizine in patients with Menière's disease. Subjective and vestibular findings.
    Haid T
    Acta Otolaryngol Suppl; 1988; 460():149-53. PubMed ID: 3074615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium entry blockers in the treatment of vertigo.
    Olesen J
    Ann N Y Acad Sci; 1988; 522():690-7. PubMed ID: 3377379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists in the prevention of motion sickness.
    Lee JA; Watson LA; Boothby G
    Aviat Space Environ Med; 1986 Jan; 57(1):45-8. PubMed ID: 3510617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of benign positional vertigo in the elderly: a randomized trial.
    Salvinelli F; Trivelli M; Casale M; Firrisi L; Di Peco V; D'Ascanio L; Greco F; Miele A; Petitti T; Bernabei R
    Laryngoscope; 2004 May; 114(5):827-31. PubMed ID: 15126738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical double blind study with the calcium antagonist flunarizine cerebral circulatory disturbances].
    Eckmann F
    Arzneimittelforschung; 1985; 35(8):1276-9. PubMed ID: 3907638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists in migraine and vertigo. Possible mechanisms of action and review of clinical trials.
    Olesen J
    Eur Neurol; 1990; 30 Suppl 2():31-4; discussion 39-41. PubMed ID: 2180716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial.
    Lepcha A; Amalanathan S; Augustine AM; Tyagi AK; Balraj A
    Eur Arch Otorhinolaryngol; 2014 Nov; 271(11):2931-6. PubMed ID: 24166742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A postmarketing study of flunarizine in migraine and vertigo.
    de Bock GH; Eelhart J; van Marwijk HW; Tromp TP; Springer MP
    Pharm World Sci; 1997 Dec; 19(6):269-74. PubMed ID: 9443168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease.
    Fraysse B; Bebear JP; Dubreuil C; Berges C; Dauman R
    Acta Otolaryngol Suppl; 1991; 490():1-10. PubMed ID: 1763646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium entry blockers in the treatment of vertebrobasilar insufficiency.
    Hofferberth B
    Eur Neurol; 1986; 25 Suppl 1():80-5. PubMed ID: 3530776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine.
    Verspeelt J; De Locht P; Amery WK
    Eur J Clin Pharmacol; 1996; 51(1):15-22. PubMed ID: 8880046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antivertiginous action of vitamin B 6 on experimental minocycline-induced vertigo in man].
    Claussen CF; Claussen E
    Arzneimittelforschung; 1988 Mar; 38(3):396-9. PubMed ID: 3382463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.